ATE232848T1 - Benzoesäurederivate und deren medizinische verwendung - Google Patents

Benzoesäurederivate und deren medizinische verwendung

Info

Publication number
ATE232848T1
ATE232848T1 AT98907277T AT98907277T ATE232848T1 AT E232848 T1 ATE232848 T1 AT E232848T1 AT 98907277 T AT98907277 T AT 98907277T AT 98907277 T AT98907277 T AT 98907277T AT E232848 T1 ATE232848 T1 AT E232848T1
Authority
AT
Austria
Prior art keywords
compound
serotonin
pharmaceutically acceptable
gastrointestinal
agent
Prior art date
Application number
AT98907277T
Other languages
English (en)
Inventor
Katsuhiko Ito
Shuji Sonda
Toshio Kawahara
Kiyoshi Asano
Takeshi Kawakita
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of ATE232848T1 publication Critical patent/ATE232848T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98907277T 1997-03-21 1998-03-16 Benzoesäurederivate und deren medizinische verwendung ATE232848T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6873997 1997-03-21
PCT/JP1998/001132 WO1998042668A1 (fr) 1997-03-21 1998-03-16 Composes d'acide benzoique et leur utilisation medicale

Publications (1)

Publication Number Publication Date
ATE232848T1 true ATE232848T1 (de) 2003-03-15

Family

ID=13382468

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907277T ATE232848T1 (de) 1997-03-21 1998-03-16 Benzoesäurederivate und deren medizinische verwendung

Country Status (4)

Country Link
EP (1) EP0979818B1 (de)
AT (1) ATE232848T1 (de)
DE (1) DE69811487D1 (de)
WO (1) WO1998042668A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2897946T3 (es) * 2013-07-25 2022-03-03 Dong A St Co Ltd Método para preparar un derivado de benzamida, intermedio novedoso utilizado en la preparación de la benzamida y método para preparar un intermedio novedoso

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970702247A (ko) * 1994-03-30 1997-05-13 고야 마사시 벤조산 화합물 및 이들의 약제로서의 용도(benzoic acid compound and use thereof as medicine)
JPH0977742A (ja) * 1995-09-12 1997-03-25 Kyorin Pharmaceut Co Ltd 新規なベンズアミド誘導体
WO1997011054A1 (en) * 1995-09-22 1997-03-27 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and medicinal use thereof
JPH09241241A (ja) * 1996-03-08 1997-09-16 Roussel Morishita Kk Ｎ−（１−置換−４−ピペリジル）ベンズアミド誘導体

Also Published As

Publication number Publication date
EP0979818A4 (de) 2000-05-31
WO1998042668A1 (fr) 1998-10-01
DE69811487D1 (de) 2003-03-27
EP0979818A1 (de) 2000-02-16
EP0979818B1 (de) 2003-02-19

Similar Documents

Publication Publication Date Title
DK0668863T3 (da) Quinuclidinderivat som substans P-antagonist
FI935134A0 (fi) Substituerade 3-aminokinuklidiner
MXPA04000278A (es) Uso de antagonistas del receptor nk-1 con estructura piridinica para tratamiento de lesiones cerebrales, espinales o neuronales.
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
SE9904508D0 (sv) New compounds
WO2003048164A3 (en) Adenosine a2a receptor antagonists
DE68914438D1 (de) N-(3,4-dimethoxycinnamoyl)-Anthranilsäure enthaltende Arzneimittelzusammensetzungen.
ATE186301T1 (de) An den positionen 2 und 9 substituierte 4h-pyrido-(1,2-a)pyrimidin-4-one
BR9807950A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, o risco de doença inflamatória o risco da dor e para a preparação de um composto
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
ES2089255T3 (es) N-(ariloxialquil)heteroaril-8-azabiciclo(3.2.1)octanos, compuestos intermedios y un procedimiento para su preparacion y su uso como medicamentos.
DE69811487D1 (de) Benzoesäurederivate und deren medizinische verwendung
NZ504124A (en) Phenyl-alkyl-imidazoles and use in treating inflammatory disease
EP1172106A3 (de) Werwendung von fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen als substanz p antagonisten
EP2266566A3 (de) Nicotinamid Derivate und ihrer Verwendung als Therapeutika
IL143873A0 (en) Dry skin remedies
DE60026559D1 (de) Arzneimittel gegen essstörungen
ATE265459T1 (de) Triazolpurin-derivate, medikamentzusammensetzungen, die diese enthalten und mittel, die affinität zum adenosin a3 rezeptor zeigen
NO951865L (no) Quinuclidin-derivat som substans-P antagonist
TH17369EX (th) อนุพันธ์ไพรโรโล-ไพริดีน

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties